Abstract #2455

Evaluate the efficiency of the ESWAN value for differentiating renal clear cell carcinoma with different pathological grades.

Xinmiao Bu¹, Ailian Liu¹, Dahua Cui¹, Xin Li², and Qingwei Song¹

¹The First Affiliated Hospital of Dalian Medical University, dalian, China, ²GE Healthcare, Beijing, China

To investigate the potential of ESWAN in differentiating renal clear cell carcinoma with different pathological grades, to help preoperative non-invasive prediction of renal clear cell carcinoma pathological grading.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.